Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Bristol-Myers Squibb |
---|---|
Information provided by: | Bristol-Myers Squibb |
ClinicalTrials.gov Identifier: | NCT00002358 |
To provide oral sorivudine ( BV-araU ) to pediatric HIV-infected patients with varicella-zoster viral disease who have failed or are intolerant of alternative therapy.
Condition | Intervention | Phase |
---|---|---|
HIV Infections Chickenpox |
Drug: Sorivudine |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Efficacy Study |
Official Title: | Open-Label BV-araU Treatment of Pediatric HIV-Infected Patients With Cutaneous, Visceral, or Ocular Varicella-Zoster Viral Disease Who Have Failed or Are Intolerant of Standard Therapy |
Ages Eligible for Study: | 2 Years to 17 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
Concurrent Medication:
Excluded:
Patients with the following prior condition are excluded:
History of immediate hypersensitivity to nucleoside analogues.
Prior Medication:
Excluded:
Required:
Study ID Numbers: | 255A, AI458-903 |
Study First Received: | November 2, 1999 |
Last Updated: | October 1, 2007 |
ClinicalTrials.gov Identifier: | NCT00002358 |
Health Authority: | United States: Food and Drug Administration |
Herpes Zoster Acquired Immunodeficiency Syndrome AIDS-Related Complex |
Antiviral Agents sorivudine Chickenpox |
Herpes Zoster Sexually Transmitted Diseases, Viral Acquired Immunodeficiency Syndrome Chickenpox AIDS-Related Complex Immunologic Deficiency Syndromes Varicella Zoster Herpesviridae Infections |
Virus Diseases HIV Infections Sexually Transmitted Diseases DNA Virus Infections Chicken pox Retroviridae Infections Sorivudine |
Anti-Infective Agents RNA Virus Infections Slow Virus Diseases Immune System Diseases Therapeutic Uses |
Lentivirus Infections Infection Antiviral Agents Pharmacologic Actions |